1
项与 Naturally occurring regulatory T cells (nTregs)(Guy's and St Thomas' NHS Foundation Trust) 相关的临床试验The ONE Study: A Unified Approach to Evaluating Cellular Immunotherapy in Solid Organ Transplantation
A study to assess cell therapy as a treatment to prevent kidney transplant rejection. The trial will involve purification of naturally occurring regulatory T cells (nTregs) from living-donor renal transplant recipients. The cells will then be grown in the laboratory and re-infused into the patient five days after the kidney transplant. This trial is part of an international European Union funded consortium aimed at evaluating cellular immunotherapy in solid organ transplantation (The ONE Study). It is anticipated that immune regulation induced by nTreg therapy can eventually be used to recude the need for conventional immunosuppression in transplant recipients.
100 项与 Naturally occurring regulatory T cells (nTregs)(Guy's and St Thomas' NHS Foundation Trust) 相关的临床结果
100 项与 Naturally occurring regulatory T cells (nTregs)(Guy's and St Thomas' NHS Foundation Trust) 相关的转化医学
100 项与 Naturally occurring regulatory T cells (nTregs)(Guy's and St Thomas' NHS Foundation Trust) 相关的专利(医药)
100 项与 Naturally occurring regulatory T cells (nTregs)(Guy's and St Thomas' NHS Foundation Trust) 相关的药物交易